Andrew May

Andrew May – Senior Director of Genome Engineering

CZ Biohub

After receiving a D.Phil. in Molecular Biophysics from the University of Oxford, May was a Wellcome Trust International Postdoctoral Fellow at Stanford University. He led development teams in single-cell genomics, sequencing, and structural proteomics at Fluidigm before becoming Chief Scientific Officer at Caribou Biosciences, where he built and led the scientific team focused on developing CRISPR-Cas technologies. At CZ Biohub, May is combining single-cell resolution analytical methods with genome-editing in primary cells and tissues to understand complex multicellular populations. He is also developing technologies to enable genome engineering of specific tissues for the treatment of genetic disorders and is building an engineering framework for the design of cellular devices that sense, monitor, record and treat disease states.